Skip Navigation LinksHome > Current Issue > Contributor Index

March 2016 - Volume 26 - Issue 3 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 1 Next
Author Name Article
Alberts, Steven R.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Altman, Russ B.

PharmGKB summary: very important pharmacogene information for RYR1

Purchase Access
PDF
+ Favorites
Request Permissions
Alvarellos, Maria L.

PharmGKB summary: very important pharmacogene information for RYR1

Purchase Access
PDF
+ Favorites
Request Permissions
Berenberg, Jeffrey L.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Boyko, Alexey

Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Canteras-Jordana, Manuel

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Carrasco-Torres, Rubén

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chan, Emily

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cho, Arthur

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cho, Byoung Chul

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
de-Miguel-Elízaga, Irene

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Diasio, Robert B.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Favorova, Olga

Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gill, Sharlene

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Goldberg, Richard M.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Grothey, Axel

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kahlenberg, Morton S.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kim, Hye Ryun

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kim, Joo Hang

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Klein, Teri E.

PharmGKB summary: very important pharmacogene information for RYR1

Purchase Access
PDF
+ Favorites
Request Permissions
Krauss, Ronald M.

PharmGKB summary: very important pharmacogene information for RYR1

Purchase Access
PDF
+ Favorites
Request Permissions
Kulakova, Olga

Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Lee, Adam M.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Lee, Min Goo

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Lim, Sun Min

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Marras, Carlos

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Martín-Fernández, Javier

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Martínez-Villanueva, Miriam

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Nair, Suresh G.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Park, Hyung Soon

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Polite, Blase

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Sargent, Daniel J.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Shi, Qian

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Shields, Anthony F.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Shin, Ho Jung

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Shin, Jae-Gook

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Sinicrope, Frank A.

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Tortosa-Conesa, Diego

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Tsareva, Ekaterina

Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Villegas-Martínez, Irene

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Wilke, Russell A.

PharmGKB summary: very important pharmacogene information for RYR1

Purchase Access
PDF
+ Favorites
Request Permissions
Yedra-Guzmán, Maria J.

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Actions
View
Show
Previous of 1 Next